NDC 72162-1735-01 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1735
- Requested NDC
- 72162-1735-01
- Package NDCs from labels
- 72162-1735-1, 72162-1735-2, 72162-1735-3, 72162-1735-4, 72162-1735-5, 72162-1735-6, 72162-1735-7, 72162-1735-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-09-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-09-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1735-1 | Acyclovir | 120 in 1 BOTTLE, PLASTIC | TABLET | 120 | 102 | |
| 72162-1735-2 | Acyclovir | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 102 | |
| 72162-1735-3 | Acyclovir | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 102 | |
| 72162-1735-4 | Acyclovir | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 102 | |
| 72162-1735-5 | Acyclovir | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | 102 | |
| 72162-1735-6 | Acyclovir | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 102 | |
| 72162-1735-7 | Acyclovir | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1735 | ACYCLOVIR TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, 7 package rows | 20240919_f09cdb3f-dfd2-4e47-bb5e-a5d26d8bcc89.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1735-1 | EA - Each | 72162-1735 | bf807b4a-bf13-47b0-92f0-62c6bc84e4db | 1 | 2023-10-16 |
| 72162-1735-2 | EA - Each | 72162-1735 | 999a483e-5326-4ee8-87e6-8fd123c683a9 | 1 | 2023-10-16 |
| 72162-1735-3 | EA - Each | 72162-1735 | 38ad4994-e407-46b8-9f2b-ed6e1e7914bc | 1 | 2023-10-16 |
| 72162-1735-4 | EA - Each | 72162-1735 | 60b855ee-7970-4008-a5fb-103c4ae7ea3a | 1 | 2023-10-16 |
| 72162-1735-5 | EA - Each | 72162-1735 | 44fa26cf-3c82-408f-a845-49cec7cb696a | 1 | 2023-10-16 |
| 72162-1735-6 | EA - Each | 72162-1735 | b231becf-f4b5-4705-8b28-6f8972065e5c | 1 | 2023-10-16 |
| 72162-1735-7 | EA - Each | 72162-1735 | a8a2b11d-7516-4dab-bb64-cf00cb211cf7 | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | e4f91376-9e18-41a4-aa5e-adcea0c625d9 | 2023-12-05 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bionpharma Inc. | 6f1db9f0-9b41-4fb7-8798-44fdc2c128df | 2023-12-03 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| Acyclovir suspension | ACYCLOVIR | Novadoz Pharmaceuticals LLC | 3efa1e5e-5a14-4724-a2ca-25702f10faed | 2023-11-03 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | 942632d8-08cd-4003-aec0-1c6d5c09bc15 | 2023-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | SQUARE PHARMACEUTICALS LIMITED | b24201ea-aeae-4de1-b01b-eee89068e786 | 2023-07-02 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | e8433261-07f1-448b-aaf4-631414598c08 | 2023-05-08 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | c40a57b9-4cf1-4a69-abf3-eb99a7fcda00 | 2023-04-16 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 34a38cdf-04e8-4006-a9f5-4a0831117d61 | 2023-02-06 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Modavar Pharmaceuticals LLC | 8de9c4f3-b800-4419-a063-8b62a0cba0fa | 2022-12-29 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Quinn Pharmaceuticals | 9ad711e4-003d-4b58-8177-32928bc42aa9 | 2022-12-20 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | d824fc07-9f03-4cb2-9bf8-ff7cc2955255 | 2022-10-09 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | PharmPak, Inc. | 8fb01f23-e2bd-6850-e053-2995a90a7cc5 | 2022-10-09 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Viona Pharmaceuticals Inc | 12df1991-fb1c-45df-acf3-706b1e8ecfc3 | 2022-10-05 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 2ca1395f-96b4-4543-8eed-bd07c62bbc7c | 2022-09-12 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | e8056ec6-d2dc-48af-8550-82726af1c5c5 | 2022-08-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 9e5b3a11-9c4b-4998-8a18-3046af1314ab | 2022-06-01 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | 33630a35-346e-43b6-9286-89e28ac0094a | 2022-06-01 | Warnings, Adverse reactions | ANDA075382 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Proficient Rx LP | c55bde35-a202-4c25-b545-e5d5e95c1175 | 2022-04-01 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Proficient Rx LP | 32aa3f42-23a1-4867-8228-e6e76cf9f135 | 2022-02-01 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Solco Healthcare US, LLC | a1d7b8ec-309d-447e-ae05-b9e89cc29948 | 2021-11-15 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.